Inflammation and platelets Flashcards

1
Q

what is the role of platelets?

A

At site of vascular injury e.g. clot, trauma, platelets adhere and stop bleeding in arteries
- Platelets stick to damage and become activated – release granular molecules to recruit more platelets for clot formation – productive response to prevent fatal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what happens if platelets are too occlusive?

A

If platelet is too occlusive: - stop oxygen delivery to tissues – ischaemia and thrombosis
- Arterial thrombosis – myocardial infarction – heart attack
- Stroke – clot in brain – ischaemia
- Uncontrolled platelet activation and aggregation leads to pathogenic thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do anti-platelet drugs work?

A

Anti-platelet drugs stops two platelet receptors
- e.g. aspirin stops recruitment phase of platelet formation
- Not many drugs available for stopping the initial phase
- can also inhibit platelet aggregation - but can cause drastic effects and cause bleeding, so not used anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how does aspirin work?

A

Aspirin blocks cox1 – prevents amplification and further recruitment - stops recruitment/amplification phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are there multiple ways to activate platelets?

A

yes there are multiple receptors and ligands which can activate and recruit platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what receptors are involved in initial recruitment of platelets?

A

e.g. GPVI, a2b1 integrins
- these are at sites of vascular injury where platelets can adhere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is P2Y12?

A

an inhibitor that blocks mediators that platelets release to prevent further recruitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is thromboinflammation?

A

where the immune system drives a clot in response to infection
- therefore, anti-platelet drugs against this don’t work, because the immune system is the driver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how can immune control of platelets be modulated?

A

Platelets encode immune receptors e.g. CLEC-2 which interacts with M1 macrophages – influences inflammatory function and migration of macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what roles and pathologies are platelets involved in?

A
  • haemostasis - prevent bleeding
  • thrombosis
  • cancer - metastasis
  • immunity
  • thromboinflammation
  • infection immunothrombosis
  • inflammation
  • vascular integrity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is inflammatory haemostasis?

A
  • occurs in absence of vascular injury
  • triggered by inflammatory reaction at sites of innate immune cell trafficking, which leaves gaps in endothelium
  • occurs in absence of platelets - only a single platelet adheres
  • platelet aims to seal the damage inflicted by immune transmigration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is inflammatory haemostasis induced?

A
  • Neutrophils transmigrate to tissue site of inflammation
  • Platelets see inflammatory damage by the immune cells – no injury, but platelets recruited – seal small bleeds
  • GPIIbIIIa Integrin-independent – only one or two platelets needed at each site – no need for aggregation
  • No vascular injury, just inflammatory response e.g. cytokines/cells disrupting endothelium – transmigration damages endothelium – platelet fixes this
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

would an anti-aggregation drug be useful in inflammatory haemostasis?

A

Drug which inhibits aggregation would be futile as only couple platelets are used - there is no aggregation to block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is inflammatory haemostasis organ-dependent?

A
  • specific receptor at the tissue site will be responsible e.g. distinct in brain, lung, skin – correcting one organ could disrupt other organs
  • need to identify one receptor present in this process for all organs
  • Inflammation is organ-dependent and depends on subendothelial matrix and stromal cells – these affect the response to the clot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how can we investigate the role of platelets in inflammatory haemostasis?

A
  • reverse arthus reaction: inject immune complexes into skin of mice to trigger local inflammation
  • WT mouse should be protected from bleeding - control
  • mouse deficient in platelets will have persistent bleeding at those sites, despite there being no injury
  • can measure haemoglobin to measure bleeding
  • can inject drugs and see their effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what other model can be used to look at inflammatory haemostasis?

A

lung inflammation induced by LPS (gram-negative bacteria component)
- LPS applied to normal mouse, no bleeding in lungs
- LPS applied to platelet-deficient mouse = bleeding in absence of injury in lungs
- measure haemoglobin to look at bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what cells/factors are involved in a platelet clot?

A

platelets
immune cells
coagulation factors
- lots of crosstalk and meshwork
- fine balance needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

does blocking GPiibiiia lead to bleeding in inflammatory haemostasis?

A

Block integrins to prevent aggregation:
- platelets still can inhibit bleeding as they don’t need to aggregate to deal with inflammatory haemostasis
- integrins are not needed in inflammatory haemostasis

19
Q

what happens when neutrophil transmigration is blocked in inflammatory haemostasis?

A
  • Induce immune complexes in skin and block neutrophil transmigration with PTX
  • No bleeding when neutrophil migration is inhibited
  • Inflammation/immune response causes bleeding
20
Q

what are the features of classical haemostasis?

A
  • platelet activation and aggregation
  • depends on platelet granule secretion
  • activated and procoagulant platelets
  • protects from injury-induced bleeding
  • blocked by anti-platelet drugs
  • similar mechanism in different organs
  • protective mechanism
21
Q

what are the features of inflammatory haemostasis?

A
  • absence of platelet aggregation
  • independent of platelet granule secretion
  • key role for procoagulant platelets
  • protects from inflammation-induced bleeding
  • resistant to anti-platelet drugs - actually makes it worse
  • organ-dependent mechanisms and involvement of distinct receptors in various vascular beds
  • protective mechanism
22
Q

what immune receptors do platelets express?

A

TLRs, CLECs, NODs
- Platelets can modulate immune response independent of leukocytes
- Can bind immune cells and amplify their function – improves neutrophil function, makes monocytes more inflammatory

23
Q

how can platelets act as immunomodulators?

A
  • improves neutrophil function, makes monocytes more inflammatory
  • Patients with higher platelet-leukocyte complexes had higher inflammatory response
  • Platelets can induce NETosis in neutrophils
  • Platelets can release microvesicles – membrane fragments containing inflammatory contents which can disseminate quickly through organs as they are small – move from local to systemic inflammation
24
Q

what are the main functions of platelets and their outcomes?

A

Platelet aggregation
= thrombosis

Platelet-leukocyte aggregates = Inflammation

Platelet-induces NETosis
= immunothrombosis

Microvesicle release
= dissemination of inflammation and thrombosis

25
Q

how do platelets regulate immune cell trafficking?

A

Platelets can affect immune cell trafficking at every step
- Inflamed epithelium – platelets adhere to endothelium and attract immune cells
- Platelets can release CXCR4 – indirect recruitment for immune cells
- Inflammatory haemostasis at site of transmigration – platelets protect vascular integrity – don’t want to block this function of platelets

26
Q

how can platelets modulate macrophage function?

A

Platelets can also enter tissue from tissue to reprogramme macrophages – controls innate immunity
- CXCL4/PF4 and CXCL12 help macrophage differentiation to M1 or M2 – platelets can shift pro/anti-inflammatory responses depending on the organ environment - highly complex

27
Q

what factors can platelets secrete to modulate the immune system?

A

If platelets activated, many immune molecules can be released
- e.g. coagulation factors, anti-microbials, chemokines, growthfactors
- Need to avoid exacerbating the system

28
Q

how do platelets induce NETosis? why is this a problem?

A

activated platelet can bind to neutrophil:
- Release a mesh clot covered in DAMPs which can then activate platelets
- Positive feedback loop of NETs and platelets – amplifies the response – high inflamed and proteolytic - vicious cycle where NET can recruit more platelets
- Need to act and block early enough in this pathway to avoid this excessive situation

29
Q

are platelet interactions with the immune system pro or anti-inflammatory?

A
  • Platelets tend to induce pro-inflammatory state in immune cells in blood
  • In tissues, platelet influence over immune phenotype depends on the state of those cells in the tissue
  • if tissue is inflammatory, platelets induce anti-inflammatory macrophages, and vice versa
  • they can directly bind immune cells
30
Q

how do platelets regulate neutrophils?

A

increase:
- adhesion and transmigration
- NET formation
- phagocytosis
- ROS production
- TF-driven coagulation

31
Q

how do platelets regulate monocytes?

A

increase:
- adhesion and transmigration
- inflammatory cytokine release
- TF-driven coagulation
- chemotaxis
- differentiation to macrophage

32
Q

how do platelets regulate macrophages?

A

increase:
- thrombosis
- bacterial trapping
- organ- and stimuli-specific increase in inflammation

but can shift macrophage from pro to anti-inflammatory, depending on the environment
- If organ is inflammatory, platelets dampen macrophage inflammation, and vice versa

33
Q

how can we investigate the role of platelets using human cells?

A

need to take cells from patients
- but to study immune cells, immunologists tend to deplete platelets first to avoid contamination
- but this doesn’t fully represent what happens in vivo

34
Q

how are platelets isolated from blood?

A

Isolate immune cells via centrifugation of patient blood
Platelets in serum - platelet-rich plasma
- Neutrophils surrounded by platelets too
- Take into consideration that immune cell isolates contain platelets which can impact immune response
- Different results due to platelet contamination which may alter results of assay
- immunologists sometimes ignore the fact that platelets are present

35
Q

how is an experiment looking at platelets and NETosis conducted?

A
  • Isolate neutrophils from blood
  • stimulate with PMA and uric acid
  • DNA stain for netosis net of chromatin
  • Positive control – induces netosis in 3 hours
  • if neutrophils cultured with platelets, netosis is amplified – this is what happens in patients
36
Q

how can platelet adhesion on inflamed endothelial cells be investigated?

A

ex vivo in real time:
- Immobilised endothelial cells to mimic vessel and perfuse blood over it
- Add TNF and TGFb inflammatory cytokines to stimulate platelets and test drugs
- Can take blood from patients, perfuse onto inflammatory endothelial cell and see effect of drug
- Dose of drug matters – these assays should assess efficacy of drug in patients with reprogrammed platelets, shouldn’t just use healthy donors as their platelets are different

37
Q

how can endothelial cell and platetet cooperation be seen in patients?

A

Blood perfusion over endothelial cells (HUVECs) at 1000s-1
- stain platelets with GFP
- Blood with haemolysis and inflammatory cells induces more clots – replicates patient pathology

38
Q

how can platelets affect inflammatory macrophage cytoskeletal remodelling?

A

Bone-marrow derived macrophages:
- IM macrophage are round and don’t migrate – stay in tissues to induce inflammation
- Live microscopy – label actin green – active but doesn’t move

If platelets added to M1 BMDM:
- Platelet labelled in orange
- IM becomes less round and become elongated – form filopodia to traffic – moves longer distances until platelets are fully phagocytosed, and then returns to anti-inflammatory state

platelets can shift inflammatory state of macrophage

39
Q

how can live imaging be used to see effect of platelets on macrophage phagocytosis?

A

Phagocytosis of E.Coli beads by macrophages
- Label bacterium and see endocytosis – when phagocytosed turned green
- If IM is added with platelets, enhanced phagocytosis for 30 mins, which then reduces

40
Q

how can the contribution of platelets to inflammation be assessed in animal models?

A

intravital imaging:
- Put mouse under microscope, label cells and image lung microcirculation

e.g. in sickle cell mice, label platelets and neutrophils and see how drug affects their interaction

41
Q

how do platelets and neutrophils interact in sickle cell mice ?

A

In control mice after hour of imaging:
- Neutrophil adheres to microcapillary

In sickle mice, there is already a high baseline of neutrophil adherence
- Pulmonary embolism via platelets which isn’t stable
– need to stabilise inflammatory clot rather than remove it
– removal could lead to migration of clot to other sites which could cause death

42
Q

what are the affects of a tyrosine kinase inhibitor on sickle cell mice?

A

Tyrosine kinase inhibitor (immune drug to treat leukaemia) – drug repurposing
- treatment reduces clot formation
- shows the need to lower immune system activity rather than block platelets
- Drug blocks the platelet clot completely by inhibiting the immune system to improve vascular function

43
Q

should platelets and immune system be studied separately?

A

no - there is so much cross-talk, so need to study in parallel, not isolation